Menu
← Oncology Approval Tracker
FDA DECISION ·
Darzalex Faspro + bortezomib + thalidomide + dexamethasone
daratumumab and hyaluronidase-fihj with bortezomib, thalidomide and dexamethasone · Janssen Biotech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation.
LAMPGEN ANALYSIS
Why it matters
The supplemental action adds subcutaneous daratumumab to a transplant-eligible induction regimen.
What research teams should watch
Verify transplant eligibility, administration route and coordination between induction and transplant teams.
PRIMARY RECORDS